Abstract
Objective:
The objective of the study was to assess the probability, and explore determinants of adverse respiratory outcome after discontinuation of inhaled corticosteroid (ICS) treatment in subjects with chronic obstructive pulmonary disease (COPD) diagnosed and treated in general practice.
Design:
Prospective unblinded ICS withdrawal study.
Subjects:
201 ICS treated COPD patients with various degrees of airflow limitation from 45 Dutch general practices.
Main outcome measures:
Probability of and time to exacerbation or unremitting worsening of respiratory symptoms after ICS discontinuation.
Results:
Mean age was 60.6 (S.D. 9.5) years, post-bronchodilator forced expiratory volume in 1s (FEV1) 65.6 (S.D. 15.7) % predicted. Overall probability of adverse respiratory outcome after ICS discontinuation was 0.37 (95% confidence interval (CI) 0.31, 0.44). Survival analysis showed that age, gender, smoking status and reversibility of airflow limitation were independent predictors of adverse respiratory outcome. For females, the adjusted hazard ratio was 2.14 (95% CI 1.31, 3.50) compared to males. For age, the hazard ratio was 1.05 (95% CI 1.02, 1.08) per year lived.
Conclusion:
Discontinuation of inhaled corticosteroids may harm patients with COPD. The probability of an adverse respiratory outcome may be higher in women, elderly patients, smokers and patients with higher bronchodilator reversibility while on inhaled steroid treatment.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schermer, T., Hendriks, A., Chavannes, N. et al. Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Prim Care Respir J 13, 48–55 (2004). https://doi.org/10.1016/j.pcrj.2003.11.005
Issue Date:
DOI: https://doi.org/10.1016/j.pcrj.2003.11.005
This article is cited by
-
Sex differences in adult asthma and COPD therapy: a systematic review
Respiratory Research (2022)
-
Kwaliteit van leven zegt weinig over de ernst van COPD
Huisarts en wetenschap (2011)
-
Het nut van de orale prednisontest bij de behandeling van COPD in de eerste lijn
Huisarts en wetenschap (2010)
-
Een richtlijn heeft niet altijd gelijk
Huisarts en wetenschap (2010)
-
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
Respiratory Research (2007)